Accueil>>Signaling Pathways>> Neuroscience>> Seizure Disorders>>Hexadecanamide

Hexadecanamide (Synonyms: NSC 3327, Palmitamide, Palmitic Amide, Palmitoyl Amide)

Catalog No.GC43821

Hexadecanamide is a primary fatty acid amide that is derived from palmitic acid (C16:0) and belongs to a class of important cell signaling lipids.

Products are for research use only. Not for human use. We do not sell to patients.

Hexadecanamide Chemical Structure

Cas No.: 629-54-9

Taille Prix Stock Qté
100mg
33,00 $US
En stock
250mg
65,00 $US
En stock
500mg
114,00 $US
En stock
1g
163,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Hexadecanamide is a primary fatty acid amide that is derived from palmitic acid (C16:0) and belongs to a class of important cell signaling lipids. While the physiological significance of this compound is not yet clear, it is reported to demonstrate weak anticonvulsant activity in a maximal electroshock seizure test in mice when compared with the endocannabinoid palmitoyl ethanolamide .

Avis

Review for Hexadecanamide

Average Rating: 5 ★★★★★ (Based on Reviews and 37 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Hexadecanamide

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.